Cargando…
Serum Cortistatin Level in Type 2 Diabetes Mellitus and Its Relationship with Nonalcoholic Fatty Liver Disease
PURPOSE: To evaluate serum cortistatin (CST) levels in type 2 diabetes mellitus (T2DM) patients with or without non-alcoholic fatty liver disease (NAFLD) and to examine the relationship between CST and NAFLD. METHODS: A total of 90 T2DM patients, which included 56 NAFLD patients (referred to as DM+N...
Autores principales: | Sun, Tiantian, Wang, Chang, Huo, Lijing, Wang, Yichao, Liu, Ke, Wei, Changmei, Zhao, Hang, Chen, Shuchun, Ren, Luping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960706/ https://www.ncbi.nlm.nih.gov/pubmed/36851999 http://dx.doi.org/10.2147/IJGM.S396315 |
Ejemplares similares
-
Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Song, Tiantian, et al.
Publicado: (2021) -
Circulating Bone Morphogenetic Protein-9 is Decreased in Patients with Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
por: Hao, Jianan, et al.
Publicado: (2022) -
Silibinin improves nonalcoholic fatty liver by regulating the expression of miR-122: An in vitro and in vivo study
por: Yang, Liying, et al.
Publicado: (2021) -
A correlation study of the relationships between nonalcoholic fatty liver disease and serum triglyceride concentration after an oral fat tolerance test
por: Hou, Xiaoyu, et al.
Publicado: (2021) -
Factors Associated with Liver Fibrosis in Chinese Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease
por: Luo, Yu, et al.
Publicado: (2023)